Searchable abstracts of presentations at key conferences in endocrinology

ea0063p593 | Diabetes, Obesity and Metabolism 2 | ECE2019

Probiotic supplementation and β-cell function in type 2 diabetes: evidence from randomized clinical trial

Kobyliak Nazarii , Mykhalchyshyn Galyna , Kyriienko Dmytro , Kononenko Liudmyla , Komisarenko Iuliia

Background: Probiotics have beneficial effect on obesity, insulin resistance and associated metabolic disorders. However, effect of probiotics on β-cell function are inconsistent.Aim: In a double-blind single center randomized placebo-controlled trials (RCT), effect of alive multistrain probiotic vs. placebo on β-cell function in type 2 diabetes patient were assessed.Methods: A total of 54 patients met the criteria for in...

ea0049oc2.4 | Diabetes Prediction and Complications | ECE2017

Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial

Kobyliak Nazarii , Kondratiuk Kateryna , Kyriienko Dmytro , Mykhalchyshyn Galyna

Background: Probiotics have beneficial effect on obesity related disorders in animal models. Despite a large number of animal data, randomized placebo-controlled trials (RCT) concluded that probiotics have a moderate effect on glycemic control-related parameters. However, effect of probiotics on insulin resistance are inconsistent.Aim: In a double-blind single center RCT, effect of alive multistrain probiotic vs placebo on insulin resistance in type 2 di...

ea0070aep437 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Hepatic steatosis indices as a predictors of vitamin D3 deficiency in patients with non-alcoholic fatty liver disease and type 2 diabetes

Mahmoud Udwan , Kobyliak Nazarii , Kyriienko Dmytro , Komisarenko Iuliia

Background: Recently, vitamin D3 deficiency is considered one of the factors associated with the development of non-alcoholic fatty liver disease (NAFLD). The aim was to evaluate steatosis indices and metabolic parameters in NAFLD depending on D3 status.Materials and methods: According to the recommendations of the European Society of Endocrinology, all patients were divided into 3 groups: group 1 – with an optimal level of vitamin D3 (30 ng/m...

ea0070aep313 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Omega-3 PUFA and probiotics as a single formulation for insulin resistance and obesity: Evidence from animals to randomized clinical studies

Kobyliak Nazarii , Falalyeyeva Tetyana , Mykhalchyshyn Galyna , Savchuk Olexiy , Kyriienko Dmytro , Ostapchenko Lyudmyla , Komisarenko Iuliia

Background: Probiotics and omega-3 polyunsaturated fatty acids supplementation (PUFA) have beneficial effect on obesity related disorders in animal models. We have previously shown, on rats with monosodium glutamate-induced obesity, that in take of the combination based on live probiotics and omega-3 PUFA is accompanied by the preventive effect concerning experimental obesity development, lead toinsulin resistance (IR) improvement and more obvious decrease of he paticsteatosis...